UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

HIV infection and coronary heart disease: mechanisms and management

Nature reviews cardiology, 2019-12, Vol.16 (12), p.745-759

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

The New England journal of medicine, 2019-12, Vol.381 (26), p.2497-2505

2019

Link zum Volltext

Verfügbarkeit prüfen

Body-Weight Fluctuations and Outcomes in Coronary Disease

The New England journal of medicine, 2017-04, Vol.376 (14), p.1332-1340

2017

Link zum Volltext

Verfügbarkeit prüfen

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Circulation (New York, N.Y.), 2018-08, Vol.138 (8), p.770-781

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Torcetrapib in Patients at High Risk for Coronary Events

The New England journal of medicine, 2007-11, Vol.357 (21), p.2109-2122

2007

Link zum Volltext

Verfügbarkeit prüfen

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?

The American journal of medicine, 2016-04, Vol.129 (4), p.384-391

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

PloS one, 2014-12, Vol.9 (12), p.e114519-e114519

2014

Link zum Volltext

Verfügbarkeit prüfen

Variations in time to benefit among clinical trials of cholesterol-lowering drugs

Journal of clinical lipidology, 2018-07, Vol.12 (4), p.857-862

2018

Link zum Volltext

Verfügbarkeit prüfen

Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials

The American journal of cardiology, 2014-06, Vol.113 (12), p.2018-2020

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non – Pre-Diabetics

Journal of the American College of Cardiology, 2015-02, Vol.65 (4), p.402-404

2015

Link zum Volltext

Verfügbarkeit prüfen

Visit-to-visit variability of lipid measurements as predictors of cardiovascular events

Journal of clinical lipidology, 2018-03, Vol.12 (2), p.356-366

2018

Link zum Volltext

Verfügbarkeit prüfen

Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys

CJC open (Online), 2021-12, Vol.3 (12), p.S1-S3

Waters, David D.

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials

The American journal of cardiology, 2015-02, Vol.115 (4), p.447-453

2015

Link zum Volltext

Verfügbarkeit prüfen

An Evidence-Based Guide to Cholesterol Lowering Guidelines

Canadian journal of cardiology, 2017-03, Vol.33 (3), p.343-349

2017

Link zum Volltext

Verfügbarkeit prüfen

The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain

Canadian journal of cardiology, 2017-03, Vol.33 (3), p.295-297

Waters, David D., MD

2017

Link zum Volltext

Verfügbarkeit prüfen

Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis

The New England journal of medicine, 2006-03, Vol.354 (12), p.1253-1263

2006

Link zum Volltext

Verfügbarkeit prüfen

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

The American journal of cardiology, 2009-08, Vol.104 (4), p.459-463

2009

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)

The American journal of cardiology, 2010-04, Vol.105 (7), p.905-911

2010

Link zum Volltext

Verfügbarkeit prüfen

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

The Lancet (British edition), 2009-02, Vol.373 (9664), p.649-658

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

European heart journal. Quality of care & clinical outcomes, 2021-11, Vol.7 (5), p.486-495

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular drugs that increase the risk of new-onset diabetes

The American heart journal, 2014-04, Vol.167 (4), p.421-428

2014

Link zum Volltext

Verfügbarkeit prüfen

Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor

Circulation (New York, N.Y.), 2018-09, Vol.138 (11), p.1113-1115

2018

Link zum Volltext

Verfügbarkeit prüfen

Carotid Intima-Media Thickness Among Human Immunodeficiency Virus–Infected Patients Without Coronary Calcium

The American journal of cardiology, 2012-03, Vol.109 (5), p.742-747

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.480

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.318)
Mit Volltextzugriff
(1.308)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.477)
Japanisch
(223)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.058)
Life Sciences & Biomedicine
(921)
Humans
(787)
Female
(476)
Male
(467)
Biological And Medical Sciences
(426)
Medical Sciences
(365)
Middle Aged
(314)
Cardiovascular System & Cardiology
(262)
Cardiac & Cardiovascular Systems
(251)
Adult
(237)
Aged
(223)
Animals
(203)
Risk Factors
(123)
Cardiology. Vascular System
(108)
Physical Sciences
(107)
Social Sciences
(96)
Heart
(91)
General & Internal Medicine
(90)
Adolescent
(86)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

HIV infection and coronary heart disease: mechanisms and management

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Body-Weight Fluctuations and Outcomes in Coronary Disease

Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

Effects of Torcetrapib in Patients at High Risk for Coronary Events

The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials

2013 Cholesterol Guidelines Revisited: Percent LDL Cholesterol Reduction or Attained LDL Cholesterol Level or Both for Prognosis?

Prediction of cardiovascular events in statin-treated stable coronary patients of the treating to new targets randomized controlled trial by lipid and non-lipid biomarkers

Variations in time to benefit among clinical trials of cholesterol-lowering drugs

Statin and the Risk of Renal-Related Serious Adverse Events: Analysis from the IDEAL, TNT, CARDS, ASPEN, SPARCL, and Other Placebo-Controlled Trials

Risk of New-Onset Diabetes and Cardiovascular Risk Reduction From High-Dose Statin Therapy in Pre-Diabetics and Non – Pre-Diabetics

Visit-to-visit variability of lipid measurements as predictors of cardiovascular events

Changing the Face of Cardiovascular Trial Participation: Moving Beyond Middle-Aged White Guys

Impact of Female Sex on Lipid Lowering, Clinical Outcomes, and Adverse Effects in Atorvastatin Trials

An Evidence-Based Guide to Cholesterol Lowering Guidelines

The Rise and Fall of Tuberculosis and Atherosclerosis: First There Is a Mountain

Effect of ACAT Inhibition on the Progression of Coronary Atherosclerosis

Plasma Triglycerides and Cardiovascular Events in the Treating to New Targets and Incremental Decrease in End-Points Through Aggressive Lipid Lowering Trials of Statins in Patients With Coronary Artery Disease

Usefulness of Heart Rate at Rest as a Predictor of Mortality, Hospitalization for Heart Failure, Myocardial Infarction, and Stroke in Patients With Stable Coronary Heart Disease (Data from the Treating to New Targets [TNT] Trial)

Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial

Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)

Cardiovascular drugs that increase the risk of new-onset diabetes

Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor

Carotid Intima-Media Thickness Among Human Immunodeficiency Virus–Infected Patients Without Coronary Calcium

Suchergebnisse filtern